pathologist dr. elizabeth hammond discusses the asco/cap her2 testing guideline revisions
Published 12 years ago • 552 plays • Length 1:23Download video MP4
Download video MP3
Similar videos
-
46:51
her2 in breast cancer: testing guidelines and new treatment approaches
-
3:24
cap-ascp-asco her2 testing and clinical decision-making in gastroesophageal adenocarcinoma guideline
-
55:51
her2 testing in breast cancer: improving ihc performance
-
24:56
her2 testing in breast cancer: asco-cap guideline update
-
8:59
guidelines and approaches to her2 testing for breast cancer
-
36:00
updates in her2 testing in breast cancer
-
57:46
evolving and emerging trends in her2 classification and reporting in breast cancer
-
35:58
her2 ihc interpretation guide (examples and challenging scenarios)
-
1:01:34
er breast cancer case panel discussion | 2022 best of breast conference
-
3:55
allred scoring for er, pr in breast cancer
-
40:33
immunohistochemistry in pathology
-
54:43
the science of her2-low breast cancer and implications for the pathology team
-
8:12
her2 testing in metastatic breast cancer
-
59:44
new perspectives on the full spectrum of her2 expression in breast cancer
-
1:03:11
how to improve her2 testing accuracy: incorporating the 2018 asco/cap focused update
-
4:19
recommendations for her2 testing in breast cancer
-
31:21
her2 testing for the pathologist: is your clinic up to date with the latest developments?
-
1:03:11
how to improve her2 testing accuracy: incorporating the 2018 asco/cap focused update
-
5:26
asco guidelines: her2 testing and clinical decision making in gastroesophageal adenocarcinoma
-
0:45
dr. hamilton on using pcr to classify risk in her2 breast cancer
-
3:20
dr. hurvitz on eliminating anthracyclines in her2 breast cancer treatment
-
4:20
pik3ca mutations in her2-positive breast cancer